IFNG and tuberculosis: The novel early secretory antigenic target-6 (ESAT-6)–free interferon-gamma release assay has comparable diagnostic performance for Mycobacterium tuberculosis (M.tb) infection as the QuantiFERON-TB Gold assay and is suitable for diagnosing M.tb infection in clinical trials of ESAT-6–containing tuberculosis vaccines.